TY - JOUR
T1 - Screening and management of atrial fibrillation in primary care
AU - Ponamgi, Shiva P.
AU - Siontis, Konstantinos C.
AU - Rushlow, David R.
AU - Graff-Radford, Jonathan
AU - Montori, Victor
AU - Noseworthy, Peter A.
N1 - Publisher Copyright:
© 2021 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to.
PY - 2021/4/12
Y1 - 2021/4/12
N2 - Atrial fibrillation is a common chronic disease seen in primary care offices, emergency departments, inpatient hospital services, and many subspecialty practices. Atrial fibrillation care is complicated and multifaceted, and, at various points, clinicians may see it as a consequenceand cause of multi-morbidity, as a silent driver of stroke risk, as a bellwether of an acute medical illness, or as a primary rhythm disturbance that requires targeted treatment. Primary care physicians in particular must navigate these priorities, perspectives, and resources to meet the needs ofindividual patients. This includes judicious use of diagnostic testing, thoughtful use of novel therapeutic agents and procedures, and providing access to subspecialty expertise. This review explores the epidemiology, screening, and risk assessment of atrial fibrillation, as well as management ofits symptoms (rate and various rhythm control options) and stroke risk (anticoagulation and other treatments), and offers a model for the integration of the components of atrial fibrillation care.
AB - Atrial fibrillation is a common chronic disease seen in primary care offices, emergency departments, inpatient hospital services, and many subspecialty practices. Atrial fibrillation care is complicated and multifaceted, and, at various points, clinicians may see it as a consequenceand cause of multi-morbidity, as a silent driver of stroke risk, as a bellwether of an acute medical illness, or as a primary rhythm disturbance that requires targeted treatment. Primary care physicians in particular must navigate these priorities, perspectives, and resources to meet the needs ofindividual patients. This includes judicious use of diagnostic testing, thoughtful use of novel therapeutic agents and procedures, and providing access to subspecialty expertise. This review explores the epidemiology, screening, and risk assessment of atrial fibrillation, as well as management ofits symptoms (rate and various rhythm control options) and stroke risk (anticoagulation and other treatments), and offers a model for the integration of the components of atrial fibrillation care.
UR - http://www.scopus.com/inward/record.url?scp=85104194028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104194028&partnerID=8YFLogxK
U2 - 10.1136/bmj.n379
DO - 10.1136/bmj.n379
M3 - Review article
C2 - 33846159
AN - SCOPUS:85104194028
VL - 373
JO - The BMJ
JF - The BMJ
SN - 0959-8146
M1 - n379
ER -